课题基金 / 基金详情

项目摘要

项目成果

You Han Bae的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): Poly(lactide-co-glycolide) (PLGA) has been widely applied in microspheres (MS) as a protein delivery carrier. However, proteins undergo physical and chemical denaturation during the fabrication of PLGA MS and release in the body. In addition, such formulations often cause undesirable and unpredictable release profiles, characterized by a burst effect and incomplete release. This makes PLGA MS appraoch unsuccessful for most labile proteins. The results from our preliminary study are a clear pointer to the validity of the role played by PEG-polycation (poly(L-histidine)) as a pH-dependent 'reversible molecular shield' in 1) preserving protein structure and preventing aggregation at water/organic interface, 2) exerting a pH buffering (protein sponge effect) in PLGA MS, 3) enhancing protein's physical stability in solution and in MS, and 4) an overall better control over release of the proteins from the PLGA MS ('all-in-one' concept). Although our preliminary results demonstrate the feasibility, there are still a number of variables which can be altered to optimize or tailor this polymer design for specific proteins, such as insulin. This includes changing the size of polyHis and copolymerizing with other amino acids to alter charge spacing or polyHis conformation. The proposal goes well beyond therapeutic proteins in suggesting potential applications for enzymes and other applications. The long-term goal of this project is to preserve >90 % bioactivity of a model protein, insulin, when released from PLGA MS and to achieve pseudozero-order release kinetics for more than one month period in in vitro and in vivo tests. The research specific aims include 1) experimental verification of optimized PEG-polyHis (or PEG-modified polyHis)/insulin complex for maximum insulin stability in aqueous solutions, in PLGA MS and during release, 2) a better control over release profile and 3) in vivo performance tests combined with biocompatibility and the fate of the diblock copolymer.
期刊论文(4)
专著(0)
科研奖励(0)
会议论文
DOI: 10.1021/mp060120z
发表时间: 2007-04
期刊: Molecular pharmaceutics
影响因子: 4.9
作者: [Ajay Taluja;Y. Bae]
通讯作者: Ajay Taluja;Y. Bae
Role of a novel multifunctional excipient poly(ethylene glycol)-block-oligo(vinyl sulfadimethoxine) in controlled release of lysozyme from PLGA microspheres.
新型多功能赋形剂聚(乙二醇)-嵌段-寡聚(乙烯基磺胺二甲氧嘧啶)在 PLGA 微球中控制溶菌酶释放中的作用。
DOI: 10.1016/j.ijpharm.2008.02.010
发表时间: 2008
期刊: International journal of pharmaceutics
影响因子: 5.8
作者: [Taluja,Ajay, Bae,YouHan]
通讯作者: Bae,YouHan
WELL-DEFINED MULTIFUNCTIONAL POLYMERIC NANOCARRIERS FOR EFFECTIVE GENE DELIVERY
  • 批准号:
    8257580
  • 项目类别:
  • 资助金额:
    $27.51万
  • 财政年份:
    2009
  • 负责人:
    You Han Bae
  • 依托单位:
WELL-DEFINED MULTIFUNCTIONAL POLYMERIC NANOCARRIERS FOR EFFECTIVE GENE DELIVERY
  • 批准号:
    7817124
  • 项目类别:
  • 资助金额:
    $27.79万
  • 财政年份:
    2009
  • 负责人:
    You Han Bae
  • 依托单位:
Intelligent Polymeric Nanogel Technology Overcoming Drug Resistance in Ovarian Ca
  • 批准号:
    7696849
  • 项目类别:
  • 资助金额:
    $31.23万
  • 财政年份:
    2009
  • 负责人:
    You Han Bae
  • 依托单位:
WELL-DEFINED MULTIFUNCTIONAL POLYMERIC NANOCARRIERS FOR EFFECTIVE GENE DELIVERY
  • 批准号:
    8085835
  • 项目类别:
  • 资助金额:
    $27.51万
  • 财政年份:
    2009
  • 负责人:
    You Han Bae
  • 依托单位:
海外基金